NOVONIX Limited (ASX:NVX) (FRA:GC3) is pleased to advise that following Shareholder approval at a General Meeting of Shareholders this morning, the Equity Raising announced on 29 May 2020 is now complete with $63 million having been raised.
NOVONIX Ltd (ASX:NVX) (FRA:GC3) is an integrated developer and supplier of high performance materials, equipment and services for the global lithium-ion battery industry with operations in the USA and Canada and sales in 14 countries.
NOVONIX is majority-owner of the PUREgraphite battery anode material Joint Venture, headquartered in Chattanooga, Tennessee, USA.
NOVONIX's mission is to accelerate the adoption of batteries for a cleaner energy future.
NOVONIX Limited (ASX:NVX) (FRA:GC3) refers to the equity raising announced on 27 May 2020, which included an institutional placement to raise $5.65 million and an entitlement offer to raise approximately $37.91 million.
NOVONIX Limited (ASX:NVX) (FRA:GC3) is pleased to advise that parties who were unable to attend the investor webinar broadcast today can watch and replay a recording of the full presentation
NOVONIX Ltd (ASX:NVX) WHAT'S NEXT? NOVONIX Technology Roadmap
NOVONIX Limited (ASX:NVX) (FRA:GC3) provides update regarding international trading in its shares following increasing levels of inbound enquiry from investors from North America and Europe during the month of June.
NOVONIX Limited (ASX:NVX) (FRA:GC3) wishes to advise it will host an investor webinar on Friday 12th June, 2020 at 10.15am AEST to discuss the recent announcement regarding its ability to manufacture single crystal NMC cathode material.
NOVONIX Limited (ASX:NVX) (FRA:GC3), in partnership with the Professor Mark Obrovac Research Group at Dalhousie University, is pleased to announce its ability to manufacture "single crystal" NMC cathode material using its proprietary Dry Particle Microgranulation (DPMG) technique.
NOVONIX Limited (ASX:NVX) (FRA:GC3) is conducting a fully underwritten ~$58.28 million equity raising
NOVONIX Limited (ASX:NVX) (FRA:GC3) is pleased to announce a significant $58.28 million capital raising, including a proposed institutional placement, a strategic placement and a rights issue to Australian and New Zealand NOVONIX shareholders, at an issue price of $0.29 per new share.
NOVONIX Limited (ASX:NVX) (FRA:GC3) is pleased to provide an update on breakthrough research coming from its research partnership with Prof. Mark Obrovac's group at Dalhousie University.